Navigation Links
Mayo Clinic finds retired NFL players at increased risk for heart problems
Date:3/27/2008

CHICAGO -- Screening for cardiovascular problems in elite-level football players should begin in high school and continue throughout the lives of college and professional players. Mayo Clinic physicians based that conclusion on the results of their new study of the cardiovascular health of 233 retired National Football League (NFL) players.

The Mayo data showed that 82 percent of NFL players under age 50 had abnormal narrowing and blockages in arteries, compared to the general population of the same age. This finding suggests that the former athletes face increased risk of experiencing high blood pressure, heart attack or stroke. The report on research conducted by the Mayo Clinic Arizona group will be presented next week at the American College of Cardiology Annual Scientific Session in Chicago.

Significance of the Mayo Clinic Study

This is the first and largest study to measure comprehensive cardiovascular performance measures on retired NFL athletes, ages 35 to 65. Its findings add to the emerging portrait of poor heart health among this group of retired athletes. The findings also suggest that players as young as high school age who are engaged in serious competitive-conference level of training and play may benefit from regular cardiovascular screening. What we hope to emphasize with our findings is that all NFL players -- retired or not -- need to undergo cardiovascular health evaluation because they may have changes in heart and vessel conditions that we can treat so they dont experience problems later in life, says Robert Hurst, M.D., Mayo Clinic cardiologist and lead researcher.

Adds chair of cardiovascular diseases at Mayo Clinic in Arizona and researcher Bijoy Khandheria, M.D.: Cardiovascular screening is readily available and needs to become a routine part of serious football players health care, beginning at the high school level for those who are engaged in a highly competitive and rigorous level of t
'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
2. Patients Do Better at Hospitals With Clinical Trials
3. Childrens Hospitals and Clinics of Minnesota COO, Julie Morath, Appointed to National Quality Forum Committee
4. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
5. Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications
6. VA to Open 14 New Clinics in Seven States
7. Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. Siemens Consortium to Construct Particle Therapy Center at the University Clinic of Schleswig-Holstein
10. SearchMedica Offers Medical Professionals Six New Specialized Clinical Web Searches
11. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...oger Williams has called for a ban on an artificia...tion of 6,000 types of medicines, food and drinks....he sweetener, which is used in cereal, chocolate a... Foundation has published reports that aspartame c...
...i Ramachandra Medical College and Research Institu... LifeCell have announced a joint venture towards e...lity in the city.// The umbilical cord blood stem ...ard to treating a variety of diseases. The focus o...
...licted with the Alzheimer's disease is expected to...y and the population explosion in developing natio...mentia which is connected to cardiovascular diseas...igure is expected to rise to 42 million, and to 81...
...e Mellon University have reported in the Journal P...s and being happy protects from chronic illness an...ch study was led by Professor Sheldon Cohen team w...lth as they feel that it enhances the immune syste...
Other Medicine News:
(Date:10/6/2008)...ial Showed REMICADE Therapy is More Likely to Indu...mpared with Standard Immunomod...wswire/ -- Data presented for the first time,from ...e Naive to,Immunomodulators and Biologic Therapy (...to care of patients with moderate to severe Crohn,...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/5/2008)... in New England Journal of Medicine reaffirm,well-...of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Conn., a...,UPLIFT (Understanding Potential Long-term Impacts...PIRIVA(R) HandiHaler(R) (tiotropium bromide,inhala...ion for up to 4,years as measured by FEV(1) (p<0.0...
(Date:10/2/2008)...rgent PC clinical success and expanded reimburseme...APOLIS, Oct. 2 /- Uroplasty...of the first patients in a new,randomized, control...Urgent,PC neuromodulation system for the treatment...rgency, urge incontinence and frequency of urinary...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 1Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 2Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 3Stem Cell Marker Controls Pair of Key Cancer Pathways 16714 1Stem Cell Marker Controls Pair of Key Cancer Pathways 16714 2Celebrex Lipitor combo may halt prostate cancer 16711 1Celebrex Lipitor combo may halt prostate cancer 16711 2Celebrex Lipitor combo may halt prostate cancer 16711 3Decrease in mortality after severe injuries in accidents 16708 1
..., 2007 /PRNewswire/ -- D-Pharm announced,today tha...protective compound DP-b99 in the treatment of acu...he European Stroke,Conference. The data will be pr...or Prof. H. C. Diener, on Thursday May 31st at,14....Conference,Center in Glasgow. The abstract for the...
...RNewswire-USNewswire/ -- Evidence is,accumulating ...,reports the June 2007 issue of Harvard Women,s He...50 and over who regularly took,antidepressants cal...) had double the rate of fractures as people not u...pression itself as a source,of endocrine changes t...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Antidepressant Use May Boost Fracture Risk, From Harvard Women's,Health Watch 2
Standard locking pliers.
The double action wire cutter has both side and end cutting capabilities.
...he companys core product. It is created using the ... for the screening of eye and non-eye diseases and...xamination basis and is non-reimbursable. The opto...field of view of the patients retina which is view...
...angular Camera ,IS2s Single Rectangular Head...nd SPECT studies. Offering flexibility, ease of us...r Head Camera is an ideal camera for bone and orga...d also acquires excellent cardiac images. Its also...
Medicine Products: